latanoprost 0.005 % / netarsudil 0.02 % Ophthalmic Solution
- RxCUI
- 2119701
- RxNorm name
- latanoprost 0.005 % / netarsudil 0.02 % Ophthalmic Solution
- Display name
- latanoprost 0.005 % / netarsudil 0.02 % Ophthalmic Solution
- Full name
- latanoprost 0.005 % / netarsudil 0.02 % Ophthalmic Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rocklatan | NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005% | Alcon Laboratories, Inc. | b1d71f41-be06-4a08-94d4-e352198f09c2 | 2026-08-27 | Warnings, Adverse reactions | 2119701 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b1d71f41-be06-4a08-94d4-e352198f09c2 | netarsudil 0.02 % / latanoprost 0.005 % Ophthalmic Solution [PSN] · latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution [SCD] · latanoprost 0.005 % / netarsudil 0.02 % Ophthalmic Solution [SY] | 3 | 14 | These highlights do not include all the information needed to use ROCKLATAN ® safely and effectively. See full prescribing information for ROCKLATAN ® . ROCKLATAN ® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, for topical ophthalmic use Initial U.S. Approval: 2019 | 20260120 |